Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_assertion type Assertion NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_head.
- NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_assertion description "[Strong cMET[pY1003] membrane immunoreactivity was expressed in 6% of 149 tumors analyzed and was significantly associated with progressive disease (P = 0.019) and shorter TTP (P = 0.041).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_provenance.
- NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_assertion evidence source_evidence_literature NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_provenance.
- NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_assertion SIO_000772 18467317 NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_provenance.
- NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_assertion wasDerivedFrom befree-20140225 NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_provenance.
- NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_assertion wasGeneratedBy ECO_0000203 NP186518.RAka6V2Bs5ji3cpSlQKRr5SZxPG3ZkSl4HGwHKHMveb1M130_provenance.